The secretary-general's "new approach" to the concept of venture capital on the interactive platform has even overturned a lot of stock prices. The Secretary of the Board of Directors of Hokuriku Pharmaceutical stated on the interactive platform that the company's equity shareholders, Shihe Gene and Zhiyou Medical, stated that they would strive to achieve an IPO at the right time and through the most appropriate way. Both companies will pay close attention to the relevant developments of the Science and Technology Innovation Board. After the market opened, Hokuriku Pharmaceutical rose to its daily limit, and the daily limit was sealed until the market closed.

In response to the board secretaries’ self-exposure of the concept of venture capital, the Shenzhen Stock Exchange issued a letter of concern to Ren Zixing this evening, requiring him to explain item by item how he fulfilled his information disclosure obligations when participating in investments in four industry merger and acquisition funds. The profit and loss distribution of the merger and acquisition fund has had a financial impact on the company in the past two years, and whether it will have a significant financial impact in 2018 and in the future. The purpose and motivation of disclosing this information on the Huayi platform, and whether there is a situation of actively catering to market hot spots and hyping the company's stock price.